WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002005808) NOVEL METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF DYSMENORRHOEA AND MENSTRUAL SIDE EFFECTS: THE USE OF PHOSPHOLIPASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/005808    International Application No.:    PCT/AU2001/000858
Publication Date: 24.01.2002 International Filing Date: 13.07.2001
Chapter 2 Demand Filed:    19.12.2001    
IPC:
A61K 31/00 (2006.01), A61K 31/192 (2006.01), A61K 31/357 (2006.01), A61K 31/437 (2006.01), A61K 31/675 (2006.01)
Applicants: THE UNIVERSITY OF QUEENSLAND [AU/AU]; St Lucia, QLD 4072 (AU) (For All Designated States Except US).
SHIELS, Ian, Alexander [AU/AU]; (AU) (For US Only).
TAYLOR, Stephen, Maxwell [AU/AU]; (AU) (For US Only).
FAIRLIE, David, Paul [AU/AU]; (AU) (For US Only)
Inventors: SHIELS, Ian, Alexander; (AU).
TAYLOR, Stephen, Maxwell; (AU).
FAIRLIE, David, Paul; (AU)
Agent: ARGAET, Victor, Peter; Davies Collison Cave, Level 3, 303 Coronation Drive, Milton, QLD 4064 (AU)
Priority Data:
PQ 8764 14.07.2000 AU (Priority Withdrawn 13.01.2003)
Title (EN) NOVEL METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF DYSMENORRHOEA AND MENSTRUAL SIDE EFFECTS: THE USE OF PHOSPHOLIPASE INHIBITORS
(FR) NOUVEAUX PROCEDES ET COMPOSITIONS DE TRAITEMENT OU DE PREVENTION DE LA DYSMENORRHEE ET DES EFFETS SECONDAIRES MENSTRUELS: UTILISATION D'INHIBITEURS DE PHOSPHOLIPASES
Abstract: front page image
(EN)The present invention discloses the use of secretory phospholipases A¿2? inhibitors in compositions and in methods for modulation of uterine contractions and for reducing or alleviating discomforting symptoms such as pain and blood loss, for the treatment and/or prophylaxis of dysmenorrhoea and related conditions and for the treatment and/or prophylaxis of premature uterine expulsion of a foetus or embryo, impending abortion or miscarriage.
(FR)L'invention concerne l'utilisation d'inhibiteurs de phospholipases sécrétrices A¿2? dans des compositions et dans des procédés servant à moduler les contractions utérines, à limiter ou à soulager des symptômes désagréables, tels que la douleur et les pertes de sang, et à effectuer le traitement thérapeutique et/ou prophylactique de la dysménorrhée et d'états apparentés, de l'expulsion utérine prématurée d'un foetus ou d'un embryon et de l'avortement involontaire ou de la fausse couche.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)